A two-year retrospective observational study of adverse drug reactions related to intravenous drug formulations

  • Ramani Gade Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India https://orcid.org/0000-0003-0133-7070
  • Neeraj Sadiq Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India
  • Shivaraj B Patil Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India
  • Venkata Rao Y Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India
  • Raghuveer B Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India
  • Yamini V Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India
  • Sindhu P Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India
Keywords: Adverse Drug Reactions, intravenous products, spontaneous report, NCC-PvPI, WHO-UMC causality scale

Abstract

Introduction: Adverse drug reactions are the major obstacles to patient safety and drug therapy monitoring.

Objectives: The present article provides information on intravenous products induced adverse drug reactions collected by spontaneous reporting method through an established pharmacovigilance wing working under NCC-PVPI in an Adverse Drug reaction monitoring center-Nalgonda, Telangana.

Methods: A total number of 100 intravenous products induced ADRs were collected from different age groups by observational retrospective study for the year January 2018 to December 2019.

Results: The results showed that the most affected age group was 20-29 yrs (28 %). The major contribution of the gender that exposed to ADRs was female- 73 % Most intravenous product induced ADRs were reported from the Department of OBG (46 %). Drug: Ceftriaxone-induced ADRs were (38 %). The most frequently reported ADR was fever and chills (56 %). Out of 100 ADRs, one was certain, 90 were probable/likely, and the remaining 9 were possible as per the WHO-causality scale.

Conclusions: In the present work, most of the ADRs were because of intravenous antibiotics followed by anesthetic agents, antiepileptic drugs, ringer lactate, dextrose normal saline, and H2 blockers.

Downloads

Download data is not yet available.

Author Biographies

Ramani Gade, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

Neeraj Sadiq, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

Shivaraj B Patil, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

Venkata Rao Y, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

Raghuveer B, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

Yamini V, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

Sindhu P, Kamineni Institute of medical sciences, Narketpally, Nalgonda,Telangana,India

Department of pharmacology

References

Akalu, S., & Belavadi, N. (2017). Pattern of adverse drug reactions due to antibiotics in a tertiary care hospital.International Journal of Basic & Clinical Pharmacology, 6(8), 2027-2031.

Chopra, D., Arora, P., Khan, S., & Dwivedi, S. (2014). Anaphylaxis following intravenous ranitidine: a rare adverse reaction of a common drug. Indian journal of pharmacology, 46(2), 234–236.

Doshi, M. S., Patel, P. P., Shah, S. P., & Dikshit, R. K. (2012). Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital. Journal of pharmacology & pharmacotherapeutics, 3(4), 308–313.

Farooqui, H. H., Mehta, A., & Selvaraj, S. (2019). Outpatient antibiotic prescription rate and pattern in the private sector in India: Evidence from medical audit data. PloS one, 14(11), e0224848.

Ferner, R. E. (2017). Adverse effects of phenytoin and fosphenytoin. Adverse drug reaction bulletin, 306(1), 1183-1186.

Giardina, C., Cutroneo, P. M., Mocciaro, E., Russo, G. T., Mandraffino, G., Basile, G., Rapisarda, F., Ferrara, R., Spina, E., & Arcoraci, V. (2018). Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Frontiers in pharmacology, 9, 350.

Jenerowicz, D., Polańska, A., Glińska, O., Czarnecka-Operacz, M., & Schwartz, R. A. (2014). Allergy to lidocaine injections: comparison of patient history with skin testing in five patients. Postepy dermatologii i alergologii, 31(3), 134–138.

Jung, I. Y., Kim, J. J., Lee, S. J., Kim, J., Seong, H., Jeong, W., Choi, H., Jeong, S. J., Ku, N. S., Han, S. H., Choi, J. Y., Song, Y. G., Park, J. W., & Kim, J. M. (2017). Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea. BioMed research international, 2017, 4304973.

Kalaiselvan, V., Srivastava, S., Singh, A., & Gupta, S. K. (2019). Pharmacovigilance in India: Present Scenario and Future Challenges. Drug safety, 42(3), 339–346.

Kaur, B. (2019). India beats many in high grade antibiotics abuse: Study. Down To Earth, 2019 Retrieved from https://www.downtoearth.org.in/news/health/india-beats-many-in-high-grade-antibiotics-abuse-study- 67949.

Konda, V., Pilla, S., Surekha, A., Subash, K., & Rao, K. (2018). Analysis of spontaneously reported cutaneous adverse drug reactions in a tertiary care teaching hospital in South India. International Journal of Basic & Clinical Pharmacology, 8(1), 27-33.

Meyboom, R. H., Hekster, Y. A., Egberts, A. C., Gribnau, F. W., & Edwards, I. R. (1997). Causal or casual? The role of causality assessment in pharmacovigilance. Drug safety, 17(6), 374–389.

Mushtaq, U., Tan, A., Tan, J. A., & Smith, W. B. (2014). Acute allergic reaction after intravenous saline injection: an unusual presentation of chlorhexidine allergy. The Medical journal of Australia, 200(10), 599–600.

Patel, T. K., & Patel, P. B. (2016). Incidence of Adverse Drug Reactions in Indian Hospitals: A Systematic Review of Prospective Studies. Current drug safety, 11(2), 128–136.

Richa, Tandon, V. R., Sharma, S., Khajuria, V., Mahajan, V., & Gillani, Z. (2015). Adverse drug reactions profile of antimicrobials: A 3-year experience, from a tertiary care teaching hospital of India. Indian journal of medical microbiology, 33(3), 393–400.

Schatz, S. N., & Weber, R. J. (2015). Adverse Drug Reactions. PSAP.CNS/Pharmacy Practice, 5-18.

Shamna, M., Dilip, C., Ajmal, M., Linu Mohan, P., Shinu, C., Jafer, C. P., & Mohammed, Y. (2014). A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 22(4), 303–308.

Vibha Varshney, Broad spectrum drugs rule India. DownToEarth, 2006. Retrieved from https://www.downtoearth.org.in/coverage/broad-spectrum-drugs-rule-india-8399

Young-Min, Y., Seung-Kwan, L., Young-Wha, C., Ji-Ho, L., Seung-Hee, P., Lee, Y. H. (2018). Adverse drug reactions to antibiotics collected by a pharmacovigilance center in Korea: an eight-year retrospective study. Journal of Allergy and Clinical Immunology, 141(2): AB87 (Suppl).

Published
2021-03-01
How to Cite
1.
Ramani Gade, Neeraj Sadiq, Shivaraj B Patil, Venkata Rao Y, Raghuveer B, Yamini V, Sindhu P. A two-year retrospective observational study of adverse drug reactions related to intravenous drug formulations. jpadr [Internet]. 2021Mar.1 [cited 2024Apr.26];2(1):22-6. Available from: http://jpadr.com/index.php/jpadr/article/view/24